Top Suppliers:I want be here
Related CAS#:
2640896-32-6 2549020-06-4
2320642-24-6 2379978-25-1
2549065-76-9 1632124-65-2
2549004-65-9 2549015-63-4
2764729-92-0 2415510-30-2

175033-36-0

175033-36-0 structure
175033-36-0 structure
  • Name: NCX-4016
  • Chemical Name: [3-(nitrooxymethyl)phenyl] 2-acetyloxybenzoate
  • CAS Number: 175033-36-0
  • Molecular Formula: C16H13NO7
  • Molecular Weight: 331.27700
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2016-02-02 20:57:39
  • Modify Date: 2026-09-21 17:00:59
  • Nitroaspirin (NCX 4016) is a nitric oxide (NO) donor and a nitro-derivative of Aspirin, which combines with Nitroaspirin to inhibit cyclooxygenase. Nitroaspirin (NCX 4016) has antithrombotic and anti-platelet properties and acts as a direct and irreversible inhibitor of COX-1. Nitroaspirin (NCX 4016) causes significant induction of cell cycle arrest and apoptosis in Cisplatin-resistant human ovarian cancer cells via down-regulation of EGFR/PI3K/STAT3 signaling and modulation of Bcl-2 family proteins[1][2][3][4].
Name [3-(nitrooxymethyl)phenyl] 2-acetyloxybenzoate
Synonyms m-NO-ASA
3-nitrooxyphenyl acetylsalicylate
2-Acetoxybenzoate-2-(1-nitroxymethyl)phenyl ester
Nitroaspirin, 10 mM in DMSO
3-(NitroxyMethyl)phenyl 2-acetoxybenzoate
NO-ASA
nitroaspirin
2-AcetyloxybenzoicAcid3-NitrooxymethylphenylEster
2-(ACETYLOXY)-3-[(NITROOXY)METHYL]PHENYL ESTER, BENZOIC ACID
Benzoic acid, 2-(acetyloxy)-, 3-[(nitrooxy)methyl]phenyl ester
NO-ASPIRIN 1
Nitric oxide-releasing aspirin
Ncx 4016
Inhibitor,Cyclooxygenase,Nitroaspirin,inhibit,NCX4016,NCX-4016,COX,Apoptosis
C102148
m-NO-aspirin
Description Nitroaspirin (NCX 4016) is a nitric oxide (NO) donor and a nitro-derivative of Aspirin, which combines with Nitroaspirin to inhibit cyclooxygenase. Nitroaspirin (NCX 4016) has antithrombotic and anti-platelet properties and acts as a direct and irreversible inhibitor of COX-1. Nitroaspirin (NCX 4016) causes significant induction of cell cycle arrest and apoptosis in Cisplatin-resistant human ovarian cancer cells via down-regulation of EGFR/PI3K/STAT3 signaling and modulation of Bcl-2 family proteins[1][2][3][4].
Related Catalog
Target

COX-1

References

[1]. Selvendiran K, et al. NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts. Cell Cycle. 2008 Jan 1;7(1):81-8.

[2]. Bertuglia S, et al. Antioxidant activity of nitro derivative of aspirin against ischemia-reperfusion in hamster cheekpouch microcirculation. Am J Physiol Gastrointest Liver Physiol. 2004 Mar;286(3):G437-43.

[3]. Corazzi T, et al. Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016). J Pharmacol Exp Ther. 2005 Dec;315(3):1331-7.

[4]. Selvendiran K, et al. NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts. Cell Cycle. 2008 Jan 1;7(1):81-8.
Density 1.347g/cm3
Boiling Point 499.3ºC at 760mmHg
Melting Point 61-62ºC
Molecular Formula C16H13NO7
Molecular Weight 331.27700
Flash Point 214.3ºC
Exact Mass 331.06900
PSA 107.65000
LogP 3.06260
Vapour Pressure 4.21E-10mmHg at 25°C
Index of Refraction 1.58
Storage condition -20°C
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

Chemsrc provides CAS#:175033-36-0 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 175033-36-0 | Chemsrc address: https://m.chemsrc.com/en/baike/27213.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2026 ChemSrc All Rights Reserved